A randomized double-blind placebo-controlled trial of probiotics in post-surgical colorectal cancer
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: cfu Lactobacillus and Bifidobacteria strains for six months on clinical outcomes and inflammatory cytokines (TNF-α, IFN-γ, IL-6, IL-10, IL-12, IL-17A, IL-17C and IL-22) in patients with colorectal cancer. METHODS: Fifty-two patients with colorectal cancer were randomized at four weeks after surgery to receive either a placebo (n = 25) or 30 billion colony-forming unit (CFU) of a mixture of six viable strains including 107 mg of Lactobacillus acidophilus BCMC® 12,130, Lactobacillus lactis BCMC® 12,451, Lactobacillus casei subsp BCMC® 12,313, Bifidobacterium longum BCMC® 02120, Bifidobacterium bifidum BCMC® 02290 and Bifidobacterium infantis BCMC® 02129 (n = 27). Patients were instructed to take the product orally twice daily for six months. Infection status, diarrhea or hospital admission were recorded throughout the study. Blood was taken pre- and post-intervention to measure TNF-α, IFN-γ, IL-6, IL-10, IL-12, IL-17A, IL-17C and IL-22 using ELISA multiplex kit. RESULTS: The majority of cases (~ 70%) were in Duke's C colorectal cancer for both groups. No surgical infection occurred and no antibiotics were required. Chemotherapy induced diarrhea was observed in both groups. Significant reduction in the level of pro-inflammatory cytokine, TNF-α, IL-6, IL-10, IL-12, IL-17A, IL-17C and IL-22 were observed in CRC patients who received probiotics as compared to pre-treatment level (P < 0.05). However, there was no significant difference in the IFN-γ in both groups. CONCLUSIONS: We have shown that probiotics containing six viable microorganisms of Lactobacillus and Bifidobacteria strains are safe to be consumed at four weeks after surgery in colorectal cancer patients and have reduced pro-inflammatory cytokines (except for IFN-gamma). Probiotic may modify intestinal microenvironment resulting in a decline in pro-inflammatory cytokines. TRIAL REGISTRATION: NCT03782428; retrospectively registered on 20th December 2018.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Global patterns and trends in colorectal cancer incidence and mortality
Arnold, M., Sierra, M. S., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2017) · Gut · doi:10.1136/gutjnl-2015-310912 · Cited by 5,228
Probiotic bacteria enhance murine and human intestinal epithelial barrier function
Madsen, K., Cornish, A., Soper, P., McKaigney, C., Jijon, H., Yachimec, C., Doyle, J., Jewell, L., & De Simone, C. (2001) · Gastroenterology · doi:10.1053/gast.2001.27224 · Cited by 1,102
Chan, S. H., Perussia, B., Gupta, J. W., Kobayashi, M., Pospísil, M., Young, H. A., Wolf, S. F., Young, D., Clark, S. C., & Trinchieri, G. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.4.869 · Cited by 961
Li, Z., Yang, S., Lin, H., Huang, J., Watkins, P. A., Moser, A. B., DeSimone, C., Song, X.-Y., & Diehl, A. M. (2003) · Hepatology · doi:10.1053/jhep.2003.50048 · Cited by 930
TNF-α in promotion and progression of cancer
Balkwill, F. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9005-3 · Cited by 915
Interleukin-12: A Cytokine at the Interface of Inflammation and Immunity
Trinchieri, G. (1998) · Advances in Immunology · doi:10.1016/s0065-2776(08)60387-9 · Cited by 760
Interleukin-6 in Aging and Chronic Disease: A Magnificent Pathway
Maggio, M., Guralnik, J. M., Longo, D. L., & Ferrucci, L. (2006) · The Journals of Gerontology: Series A · doi:10.1093/gerona/61.6.575 · Cited by 692
Di Giacinto, C., Marinaro, M., Sanchez, M., Strober, W., & Boirivant, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3237 · Cited by 524
Probiotics-host communication: Modulation of signaling pathways in the intestine
Thomas, C. M., & Versalovic, J. (2010) · Gut Microbes · doi:10.4161/gmic.1.3.11712 · Cited by 457
Touchefeu, Y., Montassier, E., Nieman, K., Gastinne, T., Potel, G., Bruley des Varannes, S., Le Vacon, F., & de La Cochetière, M. F. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12878 · Cited by 425
Emerging cytokine networks in colorectal cancer
West, N. R., McCuaig, S., Franchini, F., & Powrie, F. (2015) · Nature Reviews Immunology · doi:10.1038/nri3896 · Cited by 396
Emerging roles of lactic acid bacteria in protection against colorectal cancer
Zhong, L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i24.7878 · Cited by 256
Iyer, C., Kosters, A., Sethi, G., Kunnumakkara, A. B., Aggarwal, B. B., & Versalovic, J. (2008) · Cellular Microbiology · doi:10.1111/j.1462-5822.2008.01137.x · Cited by 228
Cytokine-Induced Modulation of Colorectal Cancer
Mager, L. F., Wasmer, M.-H., Rau, T. T., & Krebs, P. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00096 · Cited by 216
Rettig, T. C. D., Verwijmeren, L., Dijkstra, I. M., Boerma, D., van de Garde, E. M. W., & Noordzij, P. G. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001342 · Cited by 180
Immunobiotics and the probiotic evolution
Clancy, R. (2003) · FEMS Immunology & Medical Microbiology · doi:10.1016/s0928-8244(03)00147-0 · Cited by 176
Prebiotics and Probiotics: Their Role in the Management of Gastrointestinal Disorders in Adults
Quigley, E. M. M. (2012) · Nutrition in Clinical Practice · doi:10.1177/0884533611423926 · Cited by 175
Kim, Y., Oh, S., Yun, H. S., Oh, S., & Kim, S. H. (2010) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2010.02859.x · Cited by 162
Lactobacillus acidophilus Could Modulate the Immune Response Against Breast Cancer in Murine Model
Maroof, H., Hassan, Z. M., Mobarez, A. M., & Mohamadabadi, M. A. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9708-x · Cited by 159
Kim, Y., Lee, D. K., Kim, D., Cho, J., Yang, J. W., Chung, M.-J., Kim, K., & Ha, N. (2008) · Archives of Pharmacal Research · doi:10.1007/s12272-001-1180-y · Cited by 153
Deficiency of Interferon-Gamma or Its Receptor Promotes Colorectal Cancer Development
Wang, L., Wang, Y., Song, Z., Chu, J., & Qu, X. (2015) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0132 · Cited by 115
Dietrich, C. G. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i42.15837 · Cited by 90
Kahouli, I., Malhotra, M., Westfall, S., Alaoui‐Jamali, M. A., & Prakash, S. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-7885-x · Cited by 79
Hassan, H., Rompola, M., Glaser, A., Kinsey, S. E., & Phillips, B. (2018) · Supportive Care in Cancer · doi:10.1007/s00520-018-4216-z · Cited by 79
Aisu, N., Tanimura, S., Yamashita, Y., Yamashita, K., Maki, K., Yoshida, Y., Sasaki, T., Takeno, S., & Hoshino, S. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2640 · Cited by 76
Tan, C. K., Said, S., Rajandram, R., Wang, Z., Roslani, A. C., & Chin, K. F. (2016) · World Journal of Surgery · doi:10.1007/s00268-016-3499-9 · Cited by 75
Reyes‐Díaz, A., Mata‐Haro, V., Hernández, J., González-Córdova, A. F., Hernández‐Mendoza, A., Reyes‐Díaz, R., Torres‐Llanez, M. J., Beltrán‐Barrientos, L. M., & Vallejo‐Córdoba, B. (2018) · Nutrients · doi:10.3390/nu10060691 · Cited by 63
Trial Watch—Immunostimulation with cytokines in cancer therapy
Vacchelli, E., Aranda, F., Bloy, N., Buqué, A., Cremer, I., Eggermont, A. M. M., Fridman, W. H., Fucikova, J. P., Galon, J., Špíšek, R., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1115942 · Cited by 62
Increased expression of interleukin‐23 associated with progression of colorectal cancer
Hu, W., Chen, H., Yen, S., Huang, H., Hsiao, C., & Chuang, J. (2016) · Journal of Surgical Oncology · doi:10.1002/jso.24505 · Cited by 35
Djaldetti, M., & Bessler, H. (2017) · FEMS Microbiology Letters · doi:10.1093/femsle/fnx014 · Cited by 33
Gwee, K., Lee, W. W., Ling, K. L., Ooi, C. J., Quak, S. H., Dan, Y. Y., Siah, K. T. H., Huang, J. G., Chua, A. S. B., Hilmi, I. N., et al. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14268 · Cited by 27
Cited by
Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer
Fong, W., Li, Q., & Yu, J. (2020) · Oncogene · doi:10.1038/s41388-020-1341-1 · Cited by 613
The Intestinal Microbiota and Colorectal Cancer
Cheng, Y., Ling, Z., & Li, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.615056 · Cited by 582
The role of gut microbiota in cancer treatment: friend or foe?
Cheng, W. Y., Wu, C.-Y., & Yu, J. (2020) · Gut · doi:10.1136/gutjnl-2020-321153 · Cited by 384
Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer
Qu, R., Zhang, Y., Ma, Y., Zhou, X., Sun, L., Jiang, C., Zhang, Z., & Fu, W. (2023) · Advanced Science · doi:10.1002/advs.202205563 · Cited by 297
Colorectal Cancer Immunotherapy: State of the Art and Future Directions
Cornista, A. M., Giolito, M. V., Baker, K., Hazime, H., Dufait, I., Datta, J., Khumukcham, S. S., De Ridder, M., Roper, J., Abreu, M. T., et al. (2023) · Gastro Hep Advances · doi:10.1016/j.gastha.2023.09.007 · Cited by 39
Metadata
- Authors
- Zaharuddin, L., Mokhtar, N. M., Muhammad Nawawi, K. N., & Raja Ali, R. A.
- Venue
- BMC Gastroenterology
- Published
- 2019-07-24
- Volume
- 19
- Issue
- 1
- Pages
- 131-131
- ISSN
- 1471-230X (ISSN-L)
- OpenAlex
- W2964276212
- Cited by
- 288
- References
- 32
- FWCI
- 19.54
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.